Unknown

Dataset Information

Protective effects of intracerebroventricular adiponectin against olfactory impairments in an amyloid β1-42 rat model.


ABSTRACT:

Background

Alzheimer's disease (AD) is characterized by cognitive impairment that eventually develops into dementia. Amyloid-beta (Aβ) accumulation is a widely described hallmark in AD, and has been reported to cause olfactory dysfunction, a condition considered an early marker of the disease associated with injuries in the olfactory bulb (OB), the hippocampus (HIPP) and other odor-related cortexes. Adiponectin (APN) is an adipokine with neuroprotective effects. Studies have demonstrated that APN administration decreases Aβ neurotoxicity and Tau hyperphosphorylation in the HIPP, reducing cognitive impairment. However, there are no studies regarding the neuroprotective effects of APN in the olfactory dysfunction observed in the Aβ rat model. The aim of the present study is to determ

SUBMITTER: Guzman-Ruiz MA 

PROVIDER: S-EPMC7927416 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature